Thanks for your thoughts Adreamer!
Like you mention, there will be a lot of upcoming activity - I'm particularly interested in the OLE entry data.
I was thinking that even with the various grants, there would still be a reasonable shortfall to the amount required for the upcoming trial.
MT definitely got my attention by commenting about Phase 1 licencing deals on Linkedin - Where we are at now.
I'm potentially reading too much into those posts - Nice to dream!
Either way, exciting times ahead. Again!
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-442
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.5¢ | $31.30K | 178.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211497 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 339960 | 5 |
View Market Depth
| Last trade - 10.30am 11/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |